Simultaneous quantification of trimethoprim metabolites in pediatric plasma.
Document Type
Article
Publication Date
5-15-2022
Identifier
DOI: 10.1016/j.jchromb.2022.123232
Abstract
The dual agent antibiotic, trimethoprim/sulfamethoxazole (TMP-SMX), has been prescribed to treat or prevent infections for over 50 years. However, there are no published validated analytical methods for the measurement of TMP metabolites in humans. We developed methodology enabling reliable quantification of TMP and 5 metabolites in human plasma. Chromatographic separation was achieved in less than 8 min using a biphenyl column. Analytes were detected in positive electrospray mode using a tandem Waters Xevo-TQ-XS mass spectrometer. Precision and accuracy values for all analytes were within 15% of nominal values during assay validation.
Journal Title
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Volume
1198
First Page
123232
Last Page
123232
Keywords
Idiosyncratic adverse drug reactions; Metabolism; Tandem mass spectrometry; Trimethoprim; Validated methodology
Recommended Citation
Tessman RT, Nolte W, Toren P, Gibson K, Vu L, Goldman J. Simultaneous quantification of trimethoprim metabolites in pediatric plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1198:123232. doi:10.1016/j.jchromb.2022.123232